Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

PHASE4RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

September 30, 2027

Study Completion Date

March 30, 2028

Conditions

MyocarditisHeart FailureEndomyocardial BiopsyCardiomyopathies, SecondaryImmunosuppression

Interventions

DRUG

Prednisone

Prednisone: 1 mg/kg daily for 4 weeks followed by gradually tapered dose for 5 months

DRUG

Azathioprine

Azathioprine: 2 mg/kg daily for 12 months

DRUG

Placebo Prednisone

DRUG

Placebo Azathioprine

Trial Locations (1)

RECRUITING

First Department of Cardiology, Medical University of Warsaw, Warsaw

All Listed Sponsors

lead

Medical University of Warsaw

OTHER

NCT04654988 - Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy. | Biotech Hunter | Biotech Hunter